Study Title
SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin Administered as a 1-Hour Infusion in Ewing Sarcoma Patients in Combination With Low Dose Irinotecan and 3'-Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging
Study Details
Description:
This study evaluates the trabectedin and irinotecan in the treatment of Ewings sarcoma, with a EWS-FLI1 mutation. Patients will also receive an infusion of 18F-FLT in combination with a Positron Emission Tomography (PET) scan to help evaluate the effect of treatment.
Sponsor:
Sarcoma Alliance for Research through Collaboration
Contacts:
SARCsarc@sarctrials.org
7349307600
Government Study Link:
NCT04067115 - Click here to see study onClinicalTrials.gov